entertainment -WSS

entertainment

author：fashion 2025-10-02 18:06:22 - browse：5

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： After decades in use, heart stents finally beat placebo

Wikipedia

knowledge

WSS

Publishing genetic code of viruses could cause disaster

New clues to why women have higher risk of autoimmune disorders

Pancreatic cancer early detection could be helped by AI

NIH chief: government has fallen behind pharma on clinical trials

Zyn nicotine pouches become unlikely player in latest culture war

Ohio still needs to do more to protect the right to abortion

Wikipedia

entertainment

entertainment

How to save PrEP access — and even expand it

The Affordable Care Act has saved billions in health care costs

DIEP, the 'gold standard' of breast reconstruction, is under threat

First transplant of an entire human eye performed

Apple is now the first public company to be valued at $3 trillion

Health Care Service Corp to buy Cigna Medicare Advantage plans

Continuity nursing helped my family in our darkest PICU moments

10 reasons why health care startups fail

State Dept. review finds Biden bears some blame for Afghanistan failures

Medical school prerequisites are outdated

knowledge

Type 2 diabetes prevention programs work at large scale: study

The Affordable Care Act has saved billions in health care costs

First transplant of an entire human eye performed

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

What health policies could hitch a ride on a spending bill?

focus

Wikipedia

knowledge

focus